Business Segments · Intangible Amortization
Biotechnology — Intangible Amortization
Danaher Biotechnology — Intangible Amortization decreased by 0.4% to $230.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $213.00M to $230.00M. Over 3 years (FY 2022 to FY 2025), Biotechnology — Intangible Amortization shows an upward trend with a 3.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ4 2025
How to read this metric
High amortization often reflects significant past M&A activity and investment in proprietary technology.
Detailed definition
The periodic expense recognized for the consumption of intangible assets, such as patents, acquired technology, and cust...
Peer comparison
Standard for companies with high M&A activity in the life sciences sector.
Metric ID:
dhr_segment_biotechnology_amortization_of_intangible_assetsHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $203.00M | $203.00M | $203.00M | $203.00M | $216.00M | $216.00M | $216.00M | $216.00M | $218.00M | $214.00M | $218.00M | $213.00M | $213.00M | $228.00M | $231.00M | $230.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +6.4% | +0.0% | +0.0% | +0.0% | +0.9% | -1.8% | +1.9% | -2.3% | +0.0% | +7.0% | +1.3% | -0.4% |
| YoY Change | — | — | — | — | +6.4% | +6.4% | +6.4% | +6.4% | +0.9% | -0.9% | +0.9% | -1.4% | -2.3% | +6.5% | +6.0% | +8.0% |
Range$203.00M – $231.00M
CAGR+3.4%
Avg YoY Growth+3.6%
Median YoY Growth+6.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's biotechnology — intangible amortization?
- Danaher (DHR) reported biotechnology — intangible amortization of $230.00M in Q4 2025.
- How has Danaher's biotechnology — intangible amortization changed year-over-year?
- Danaher's biotechnology — intangible amortization increased by 8.0% year-over-year, from $213.00M to $230.00M.
- What is the long-term trend for Danaher's biotechnology — intangible amortization?
- Over 3 years (2022 to 2025), Danaher's biotechnology — intangible amortization has grown at a 3.6% compound annual growth rate (CAGR), from $812.00M to $902.00M.
- What does biotechnology — intangible amortization mean?
- The non-cash expense for the gradual write-off of acquired intangible assets.